Loading...
| A01845 | Pages: 401 | Nov 2021 | 32839 Views | | |
| Author(s) : Hemalatha Kandula, Monika Darandale , Onkar Sumant | Tables: 140 | Charts: 86 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Orthopedic Implants Market
Request Now !Global orthopedic implants market accounted for $45,053 million in 2020 is expected to reach $68,804.1 million by 2030, registering a CAGR of 4.7% from 2020 to 2030.
The COVID-19 pandemic has negatively impacted orthopedic implant market as hospital and healthcare services were significantly reduced due to social distancing measures taken by governments across the world. In addition, as many hospitals and clinics remained closed due to lockdown, the demand for orthopedic implants is expected to be subdued in the short term. Thus, the outbreak of COVID-19 has negatively impacted the market.
Orthopedic implant is a medical device manufactured to replace a missing joint or bone or to support a damaged bone. The medical implant is mainly fabricated using stainless steel and titanium alloys for strength and the plastic coating that is done on it acts as an artificial cartilage. These are primarily used in minimally invasive surgeries that are used for treating spinal injuries and lumbar spinal stenosis.
Get more information on this report : Request Sample Pages
Increase in prevalence of orthopedic injuries or diseases such as arthritis, osteoarthritis, and the rapid rise in geriatric population who are more prone to orthopedic disorders are some factors that drive the growth of the market. In addition, technological innovations, such as robot-assisted surgical tools, acceptance for implantable medical devices, and widespread application of orthopedic implants to treat musculoskeletal, orthopedic diseases, & injuries further supplement the market growth. However, high cost associated with procedures involving orthopedic implants for treatment and stringent government policies hamper the market growth. Furthermore, the emerging economies present lucrative opportunities for the market.
The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. Moreover, there has also been a negative effect on various services, including orthopedic implant. For instance, according to the Commonwealth Fund, it was estimated that there was a nearly 60% initial decrease in overall outpatient visits by May 2020 due to COVID-19. This was expected to negatively affect the demand for orthopedic sessions as they are usually conducted in outpatient departments. In addition, according to article published in Europe PMC, the pandemic has affected outpatient clinics, emergency and elective surgery, rehabilitation, resident training, personnel management, use of personal protective equipment, telemedicine, and all sub-specialties of orthopedics.
The outbreak of COVID-19 impacted the market, as hospital and healthcare services were significantly reduced due to social distancing measures taken by governments across the world. Moreover, the COVID-19 pandemic affected the global economy and showed a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals across the globe. As many hospitals and clinics remain closed due to lockdowns, the demand for orthopedic implants is expected to be subdued in the short term. For instance, according to a study published in the British Journal of Surgery, in May 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed in 2020.
The global medical cannabis market is segmented on the basis of product, type, biomaterial, and region to provide a detailed assessment of the market. Based on product, the market is divided into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics, and others that include sports medicine, cages, angled blades, power tools, arc bars, bone taps, cannulated reamers, bone hooks, bone levers retractors, distractors, finger implants, skull implants, sutures, jawbone implants, arm implants, and pelvis implants. The reconstructive joint replacements segment is again segmented into knee replacement implants, hip replacement implants, and extremities include upper extremity reconstruction, and lower extremity reconstruction. In addition, spinal implants segment is further divided into spinal fusion implants, vertebral compression fracture (VCF) devices, and motion preservation devices/non-fusion devices. Furthermore, dental implant is again classified into root form dental implants and plate form dental implants. Moreover, orthobiologics segment is further segmented into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others.
On the basis of type, the market is classified into knee, hip, wrist & shoulder, dental, spine, ankle, and others that include finger implants, thigh implants, elbow implants, maxillofacial implants, and others. Depending on biomaterial, it is differentiated into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others that include protein and polysaccharide. Metallic biomaterials are further segmented into stainless steel, titanium alloy, cobalt alloy, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Based on product, the market is segmented into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics, and others that include sports medicine, cages, angled blades, power tools, arc bars, bone taps, cannulated reamers, bone hooks, bone levers retractors, distractors, finger implants, skull implants, sutures, jawbone implants, arm implants, and pelvis implants. The reconstructive joint replacements segment is again segmented into knee replacement implants, hip replacement implants, extremities include upper extremity reconstruction, and lower extremity reconstruction. In addition, spinal implants segment is further divided into spinal fusion implants, vertebral compression fracture (VCF) devices, and motion preservation devices/non-fusion devices. Furthermore, dental implant is again classified into root form dental implants and plate form dental implants. Moreover, orthobiologics segment is further segmented into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others. The reconstructive joint replacements segment is estimated to garner largest share during the forecast period. This segment is expected to maintain its dominant position throughout the analysis period, owing to rise in prevalence of osteoporosis and osteoarthritis, and investment of key players in R&D of orthopedic implants. On the other side, the orthobiologics segment is the fastest growing segment during the forecast period, owing to rise in demand for advanced therapies, minimally invasive procedures, and surge in patient awareness toward the use of orthobiologics.
Get more information on this report : Request Sample Pages
Based on biomaterial, it is classified into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others that include protein and polysaccharide. Metallic biomaterials are further segmented into stainless steel, titanium alloy, cobalt alloy, and others. The metallic biomaterials segment occupied the largest share in 2020, owing to cost-effectiveness of these materials. Metallic biomaterials provide efficacy of bone healing as compared to other materials. These are used to manufacture various orthopedic implants such as screws, plates, vertebral compression fracture (VCF) devices, and others. However, other biomaterials are estimated to register the highest CAGR during the forecast period. This is due to the growing demand for these materials, owing to their several advantages over synthetic biomaterials. These advantages include biocompatibility, no toxicity, and may also carry specific protein binding sites and other biochemical signals that can help in the process of tissue healing or integration.
Based on type, it is segmented into knee, hip, wrist & shoulder, dental, spine, ankle, and others include finger implants, thigh implants, elbow implants, maxillofacial implants, and others. The knee segment accounted for the highest share in 2020, and is anticipated to maintain this trend during the forecast period, owing to increase in demand for knee implants due to increase in prevalence of orthopedic diseases and rise in road accidents, sport injuries, and others. However, spine is estimated to register the highest CAGR during the forecast period due to increase in geriatric population, rise in incidence of spinal disorders, and expansion in the indications for which spinal fusion surgery is performed.
Get more information on this report : Request Sample Pages
Asia-Pacific offers profitable opportunities for key players operating in the orthopedic implants market, thereby registering the fastest growth rate during the forecast period, owing to development in healthcare infrastructure, improvement in health awareness, and rise in diagnosis. Moreover, increase in the number of surgical procedures in emerging economies, such as India and China, is the major factor that fuels the market growth.
The key market players profiled in the report include Johnson & Johnson (DePuy Synthes), Zimmer Biomet Holdings, Inc., Stryker Corporation, Medtronic Plc, NuVasive, Inc., Smith and Nephew Plc., CONMED Corporation., Arthrex, Inc., DJO Finance LLC, and Globus Medical Inc.
Get more information on this report : Request Sample Pages
Key Benefits For Stakeholders
Key Market Segments
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Patent analysis, 2018–2021
3.5.1.Patent analysis, world
3.5.2.Patent analysis, by year
3.6.Market dynamics
3.6.1.Drivers
3.6.1.1.Rise in prevalence of orthopedic diseases
3.6.1.2.Surge in global geriatric population
3.6.1.3.Advancements in the field of orthopedic implants
3.6.1.4.Rise in adoption of orthopedic implants
3.6.2.Restraints
3.6.2.1.High costs associated with orthopedic implant procedures
3.6.2.2.Stringent government approval process
3.6.3.Opportunity
3.6.3.1.High market potential in emerging economies
3.6.4.Impact Analyses
3.1.COVID-19 Impact analysis on the orthopedic Implants market
CHAPTER 4:ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Reconstructive joint replacements
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.4.1.Knee Replacement Implants
4.2.4.1.1.Market size and forecast
4.2.4.2.Hip Replacement Implants
4.2.4.2.1.Market size and forecast
4.2.4.3.Extremities
4.2.4.3.1.Market size and forecast, by type
4.2.4.3.2.Upper Extremity Reconstruction
4.2.4.3.2.1.Market size and forecast, by type
4.2.4.3.2.2.Shoulder
4.2.4.3.2.3.Market size and forecast
4.2.4.3.2.4.Elbow
4.2.4.3.2.5.Market size and forecast
4.2.4.3.2.6.Hand Wrist
4.2.4.3.2.7.Market size and forecast
4.2.4.3.3.Lower Extremity Reconstruction
4.2.4.3.3.1.Market size and forecast, by type
4.2.4.3.3.2.Upper Extremity
4.2.4.3.3.3.Market size and forecast
4.2.4.3.3.4.Lower Extremity
4.2.4.3.3.5.Market size and forecast
4.3.Spinal Implants
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.4.1.Spinal fusion implants
4.3.4.1.1.Market size and forecast
4.3.4.1.2.Thoracolumbar devices
4.3.4.1.2.1.Market size and forecast
4.3.4.1.3.Cervical fixation devices
4.3.4.1.3.1.Market size and forecast
4.3.4.1.4.Interbody fusion devices
4.3.4.1.4.1.Market size and forecast
4.3.4.2.Vertebral Compression Fracture (VCF) Devices
4.3.4.2.1.Market size and forecast, type
4.3.4.2.2.Balloon Kyphoplasty Devices
4.3.4.2.2.1.Market size and forecast
4.3.4.2.3.Vertebroplasty Devices
4.3.4.2.3.1.Market size and forecast
4.3.4.3.Motion Preservation Devices/Non-Fusion Devices
4.3.4.3.1.Market size and forecast, type
4.3.4.3.2.Dynamic Stabilization Devices
4.3.4.3.2.1.Market size and forecast
4.3.4.3.3.Artificial Disc Replacement Devices
4.3.4.3.3.1.Market size and forecast
4.3.4.3.4.Annulus Repair Devices
4.3.4.3.4.1.Market size and forecast
4.3.4.3.5.Nuclear Disc Prostheses
4.3.4.3.5.1.Market size and forecast
4.4.Dental Implants
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.4.1.Root Form Dental Implant
4.4.4.1.1.Market size and forecast
4.4.4.2.Plate Form Dental Implants
4.4.4.2.1.Market size and forecast
4.5.Trauma
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.6.Orthobiologics
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
4.6.4.Market size and forecast, by type
4.6.4.1.Demineralized Bone Matrix (DBM)
4.6.4.1.1.Market size and forecast
4.6.4.2.Allograft
4.6.4.2.1.Market size and forecast
4.6.4.3.Bone Morphogenetic Protein (BMP)
4.6.4.3.1.Market size and forecast
4.6.4.4.Viscosupplementation Products
4.6.4.4.1.Market size and forecast
4.6.4.5.Synthetic Bone Substitutes
4.6.4.5.1.Market size and forecast
4.6.4.6.Others
4.6.4.6.1.Market size and forecast
4.7.Others
4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market analysis, by country
CHAPTER 5:ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL
5.1.Overview
5.1.1.Market size and forecast
5.2.Metallic Biomaterials
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.2.3.Market size and forecast, by type
5.2.3.1.Stainless Steel
5.2.3.1.1.Market size and forecast
5.2.3.2.Titanium Alloy
5.2.3.2.1.Market size and forecast
5.2.3.3.Cobalt Alloy
5.2.3.3.1.Market size and forecast
5.2.3.4.Others
5.2.3.4.1.Market size and forecast
5.3.Ceramic Biomaterials
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Polymeric Biomaterials
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Others
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
CHAPTER 6:ORTHOPEDIC IMPLANTS MARKET, BY TYPE
6.1.Overview
6.1.1.Market size and forecast
6.2.Knee
6.2.1.Market size and forecast, by region
6.2.2.Market share analysis, by country
6.3.Hip
6.3.1.Market size and forecast, by region
6.3.2.Market share analysis, by country
6.4.Wrist & Shoulder
6.4.1.Market size and forecast, by region
6.4.2.Market share analysis, by country
6.5.Dental
6.5.1.Market size and forecast, by region
6.5.2.Market share analysis, by country
6.6.Spine
6.6.1.Market size and forecast, by region
6.6.2.Market share analysis, by country
6.7.Ankle
6.7.1.Market size and forecast, by region
6.7.2.Market share analysis, by country
6.8.Others
6.8.1.Market size and forecast, by region
6.8.2.Market share analysis, by country
CHAPTER 7:ORTHOPEDIC IMPLANTS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. orthopedic implants market, by product
7.2.2.1.2.U.S. orthopedic implants market, by biomaterial
7.2.2.1.3.U.S. orthopedic implants market, by type
7.2.2.2.Canada
7.2.2.2.1.Canada orthopedic implants market, by product
7.2.2.2.2.Canada orthopedic implants market, by biomaterial
7.2.2.2.3.Canada orthopedic implants market, by type
7.2.2.3.Mexico
7.2.2.3.1.Mexico orthopedic implants market, by product
7.2.2.3.2.Mexico orthopedic implants market, by biomaterial
7.2.2.3.3.Mexico orthopedic implants market, by type
7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by biomaterial
7.2.5.North America market size and forecast, by type
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany orthopedic implants market, by product
7.3.2.1.2.Germany orthopedic implants market, by biomaterial
7.3.2.1.3.Germany orthopedic implants market, by type
7.3.2.2.France
7.3.2.2.1.France orthopedic implants market, by product
7.3.2.2.2.France orthopedic implants market, by biomaterial
7.3.2.2.3.France orthopedic implants market, by type
7.3.2.3.UK
7.3.2.3.1.UK orthopedic implants market, by product
7.3.2.3.2.UK orthopedic implants market, by biomaterial
7.3.2.3.3.UK orthopedic implants market, by type
7.3.2.4.Italy
7.3.2.4.1.Italy orthopedic implants market, by product
7.3.2.4.2.Italy orthopedic implants market, by biomaterial
7.3.2.4.3.Italy orthopedic implants market, by type
7.3.2.5.Spain
7.3.2.5.1.Spain orthopedic implants market, by product
7.3.2.5.2.Spain orthopedic implants market, by biomaterial
7.3.2.5.3.Spain orthopedic implants market, by type
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe orthopedic implants market, by product
7.3.2.6.2.Rest of Europe orthopedic implants market, by biomaterial
7.3.2.6.3.Rest of Europe orthopedic implants market, by type
7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by biomaterial
7.3.5.Europe market size and forecast, by type
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan orthopedic implants market, by product
7.4.2.1.2.Japan orthopedic implants market, by biomaterial
7.4.2.1.3.Japan orthopedic implants market, by type
7.4.2.2.China
7.4.2.2.1.China orthopedic implants market, by product
7.4.2.2.2.China orthopedic implants market, by biomaterial
7.4.2.2.3.China orthopedic implants market, by type
7.4.2.3.Australia
7.4.2.3.1.Australia orthopedic implants market, by product
7.4.2.3.2.Australia orthopedic implants market, by biomaterial
7.4.2.3.3.Australia orthopedic implants market, by type
7.4.2.4.India
7.4.2.4.1.India orthopedic implants market, by product
7.4.2.4.2.India orthopedic implants market, by biomaterial
7.4.2.4.3.India orthopedic implants market, by type
7.4.2.5.South Korea
7.4.2.5.1.South Korea orthopedic implants market, by Product
7.4.2.5.2.South Korea orthopedic implants market, by biomaterial
7.4.2.5.3.South Korea orthopedic implants market, by type
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific orthopedic implants market, by product
7.4.2.6.2.Rest of Asia-Pacific orthopedic implants market, by biomaterial
7.4.2.6.3.Rest of Asia-Pacific orthopedic implants market, by type
7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by biomaterial
7.4.5.Asia-Pacific market size and forecast, by type
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil orthopedic implants market, by product
7.5.2.1.2.Brazil orthopedic implants market, by biomaterial
7.5.2.1.3.Brazil orthopedic implants market, by type
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia orthopedic implants market, by product
7.5.2.2.2.Saudi Arabia orthopedic implants market, by biomaterial
7.5.2.2.3.Saudi Arabia orthopedic implants market, by type
7.5.2.3.South Africa
7.5.2.3.1.South Africa orthopedic implants market, by product
7.5.2.3.2.South Africa orthopedic implants market, by biomaterial
7.5.2.3.3.South Africa orthopedic implants market, by type
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA orthopedic implants market, by product
7.5.2.4.2.Rest of LAMEA orthopedic implants market, by biomaterial
7.5.2.4.3.Rest of LAMEA orthopedic implants market, by type
7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by biomaterial
7.5.5.LAMEA market size and forecast, by type
CHAPTER 8:COMPANY PROFILES
8.1.ARTHREX, INC.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Biomaterial portfolio
8.1.5.Key strategic moves and developments
8.2.CONMED CORPORATION
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.3.Colfax Corporation (DJO GLOBAL LLC)
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.GLOBUS MEDICAL INC.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.JOHNSON & JOHNSON (DEPUY SYNTHES)
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.MEDTRONIC PLC.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.NuVasive, Inc.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product Portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.SMITH & NEPHEW PLC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.STRYKER CORPORATION
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.ZIMMER BIOMET HOLDINGS, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 02.ORTHOPEDIC IMPLANTS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENT, BY REGION, 2020-2030($MILLION)
TABLE 03.RECONSTRUCTIVE JOINT REPLACEMENTS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 04.EXTREMITIES MARKET, BY TYPE 2020–2030 ($MILLION)
TABLE 05.UPPER EXTREMITIES RECONSTRUCTION MARKET, BY TYPE 2020–2030 ($MILLION)
TABLE 06.LOWER EXTREMITIES RECONSTRUCTION MARKET, BY TYPE 2020–2030 ($MILLION)
TABLE 07.ORTHOPEDIC IMPLANTS MARKET FOR SPINAL IMPLANTS, BY REGION, 2020-2030($MILLION)
TABLE 08.SPINAL IMPLANTS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 09.SPINAL FUSION IMPLANTS MARKET, BY TYPE 2020–2030 ($MILLION)
TABLE 10.VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES MARKET, BY TYPE 2020–2030 ($MILLION)
TABLE 11.MOTION PRESERVATION DEVICES/NON-FUSION DEVICES MARKET, BY TYPE 2020–2030 ($MILLION)
TABLE 12.ORTHOPEDIC IMPLANTS MARKET FOR DENTAL IMPLANTS, BY REGION, 2020-2030($MILLION)
TABLE 13.DENTAL IMPLANTS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 14.TRAUMA ORTHOPEDIC IMPLANTS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 15.ORTHOPEDIC IMPLANTS MARKET FOR ORTHOBIOLOGICS, BY REGION, 2020-2030($MILLION)
TABLE 16.ORTHOBIOLOGICS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 17.ORTHOPEDIC IMPLANTS MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 18.ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020–2030 ($MILLION)
TABLE 19.ORTHOPEDIC IMPLANTS MARKET FOR METALLIC BIOMATERALS, BY REGION, 2020-2030($MILLION)
TABLE 20.METALLIC BIOMATERIALS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 21.ORTHOPEDIC IMPLANT MARKET FOR CERAMIC BIOMATERIAL, BY REGION, 2020–2030 ($MILLION)
TABLE 22.ORTHOPEDIC IMPLANTS MARKET FOR POLYMERIC BIOMATERIALS, BY REGION, 2020–2030 ($MILLION)
TABLE 23.ORTHOPEDIC IMPLANTS MARKET FOR OTHERS BIOMATERIAL, BY REGION, 2020–2030 ($MILLION)
TABLE 24.ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 25.ORTHOPEDIC IMPLANTS MARKET FOR KNEE, BY REGION, 2020–2030 ($MILLION)
TABLE 26.ORTHOPEDIC IMPLANTS MARKET FOR HIP, BY REGION, 2020–2030 ($MILLION)
TABLE 27.ORTHOPEDIC IMPLANTS MARKET FOR WRIST & SHOULDER, BY REGION, 2020–2030 ($MILLION)
TABLE 28.ORTHOPEDIC IMPLANTS MARKET FOR DENTAL, BY REGION, 2020–2030 ($MILLION)
TABLE 29.ORTHOPEDIC IMPLANTS MARKET FOR SPINE, BY REGION, 2020–2030 ($MILLION)
TABLE 30.ORTHOPEDIC IMPLANTS MARKET FOR ANKLE, BY REGION, 2020–2030 ($MILLION)
TABLE 31.ORTHOPEDIC IMPLANTS MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 32.ORTHOPEDIC IMPLANTS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 33.NORTH AMERICA ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 34.U.S. ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 35.U.S. ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 36.U.S. ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 37.CANADA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 38.CANADA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 39.CANADA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 40.MEXICO ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 41.MEXICO ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 42.MEXICO ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 43.NORTH AMERICA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 44.NORTH AMERICA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 45.NORTH AMERICA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 46.EUROPE ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 47.GERMANY ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 48.GERMANY ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 49.GERMANY ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 50.FRANCE ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 51.FRANCE ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 52.FRANCE ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 53.UK ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 54.UK ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 55.UK ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 56.ITALY ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 57.ITALY ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 58.ITALY ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 59.SPAIN ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 60.SPAIN ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 61.SPAIN ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 62.REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 63.REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 64.REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 65.EUROPE ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 66.EUROPE ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 67.EUROPE ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 68.ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 69.JAPAN ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 70.JAPAN ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 71.JAPAN ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 72.CHINA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 73.CHINA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 74.CHINA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 75.AUSTRALIA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 76.AUSTRALIA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 77.AUSTRALIA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 78.INDIA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 79.INDIA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 80.INDIA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 81.SOUTH KOREA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 82.SOUTH KOREA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 83.SOUTH KOREA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 84.REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 85.REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 86.REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 87.ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 88.ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 89.ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 90.LAMEA ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 91.BRAZIL ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 92.BRAZIL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 93.BRAZIL ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 94.SAUDI ARABIA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 95.SAUDI ARABIA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 96.SAUDI ARABIA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 97.SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 98.SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 99.SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, BY TYPE 2020-2030($MILLION)
TABLE 100.REST OF LAMEA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 101.REST OF LAMEA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 102.REST OF LAMEA ORTHOPEDIC IMPLANTS MARKET, TYPE, 2020-2030($MILLION)
TABLE 103.LAMEA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 104.LAMEA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2020-2030($MILLION)
TABLE 105.LAMEA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 106.ARTHREX: COMPANY SNAPSHOT
TABLE 107.ARTHREX: OPERATING SEGMENTS
TABLE 108.ARTHREX: PRODUCT PORTFOLIO
TABLE 109.ARTHREX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110.CONMED: COMPANY SNAPSHOT
TABLE 111.CONMED: PRODUCT PORTFOLIO
TABLE 112.COLFAX: COMPANY SNAPSHOT
TABLE 113.COLFAX: OPERATING SEGMENTS
TABLE 114.COLFAX: PRODUCT PORTFOLIO
TABLE 115.COLFLAX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 116.GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 117.GLOBUS MEDICAL, INC.: OPERATING SEGMENTS
TABLE 118.GLOBUS MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 119.GLOBUS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120.J&J: COMPANY SNAPSHOT
TABLE 121.J&J: OPERATING SEGMENTS
TABLE 122.J&J: PRODUCT PORTFOLIO
TABLE 123.MEDTRONIC: COMPANY SNAPSHOT
TABLE 124.MEDTRONIC: OPERATING SEGMENTS
TABLE 125.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 126.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127.NUVASIVE: COMPANY SNAPSHOT
TABLE 128.NUVASIVE: PRODUCT LINE
TABLE 129.NUVASIVE: PRODUCT PORTFOLIO
TABLE 130.NUVASIVE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 131.SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 132.SMITH & NEPHEW: PRODUCT SEGMENTS
TABLE 133.SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 134.SMITH & NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 135.STRYKER: COMPANY SNAPSHOT
TABLE 136.STRYKER: OPERATING SEGMENTS
TABLE 137.STRYKER: PRODUCT PORTFOLIO
TABLE 138.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 139.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 140.ZIMMER BIOMET: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.ORTHOPEDIC IMPLANTS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06.MODERATE BARGANING POWER OF BUYERS
FIGURE 07.HIGH BARGANING POWER OF SUPPLIERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTION
FIGURE 09.LOW THREAT OF NEW ENTRANTS
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.PATENTS REGISTERED/APPROVED IN THE WORLD, 2018-2021
FIGURE 13.PATENTS ANALYSIS, BY YEAR, 2018–2021
FIGURE 14.IMPACT ANALYSES, ORTHOPEDIC IMPLANTS MARKET
FIGURE 15.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENT, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.KNEE REPLACEMENT IMPLANTS MARKET, 2020–2030 ($MILLION)
FIGURE 17.HIP REPLACEMENT IMPLANTS MARKET, 2020–2030 ($MILLION)
FIGURE 18.SHOULDER IMPLANTS MARKET, 2020–2030 ($MILLION)
FIGURE 19.ELBOW IMPLANTS MARKET, 2020–2030 ($MILLION)
FIGURE 20.HAND WRIST IMPLANTS MARKET, 2020–2030 ($MILLION)
FIGURE 21.UPPER EXTREMITY IMPLANTS MARKET, 2020–2030 ($MILLION)
FIGURE 22.LOWER EXTREMITY IMPLANTS MARKET, 2020–2030 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR SPINAL IMPALNTS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 24.THORACOLUMBAR DEVICES MARKET, 2020–2030 ($MILLION)
FIGURE 25.CERVICAL FIXATION DEVICES MARKET, 2020–2030 ($MILLION)
FIGURE 26.INTERBODY FUSION DEVICES MARKET, 2020–2030 ($MILLION)
FIGURE 27.BALLOON KYPHOPLASTY DEVICES MARKET, 2020–2030 ($MILLION)
FIGURE 28.VERTEBROPLASTY DEVICES MARKET, 2020–2030 ($MILLION)
FIGURE 29.DYNAMIC STABILIZATION DEVICES MARKET, 2020–2030 ($MILLION)
FIGURE 30.ARTIFICIAL DISC REPLACEMENT DEVICES MARKET, 2020–2030 ($MILLION)
FIGURE 31.ANNULUS REPAIR DEVICE MARKET, 2020–2030 ($MILLION)
FIGURE 32.NUCLEAR DISC PROSTHESES MARKET, 2020–2030 ($MILLION)
FIGURE 33.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR DENTAL IMPLANTS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 34.ROOT FORM DENTAL IMPLANTS MARKET, 2020–2030 ($MILLION)
FIGURE 35.PLATE FORM DENTAL IMPLANTS MARKET, 2020–2030 ($MILLION)
FIGURE 36.COMPARATIVE ANALYSIS OF TRAUMA ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2020 & 2030
FIGURE 37.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR ORTHOBIOLOGICS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 38.DEMINERALIZED BONE MATRIX (DBM) MARKET, 2020–2030 ($MILLION)
FIGURE 39.ALLOGRAFT MARKET, 2020–2030 ($MILLION)
FIGURE 40.BONE MORPHOGENETIC PROTEIN (BMP) MARKET, 2020–2030 ($MILLION)
FIGURE 41.VISCOSUPPLEMENTATION PRODUCTS MARKET, 2020–2030 ($MILLION)
FIGURE 42.SYNTHETIC BONE SUBSTITUTES MARKET, 2020–2030 ($MILLION)
FIGURE 43.OTHERS MARKET, 2020–2030 ($MILLION)
FIGURE 44.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 45.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR METALLIC BIOMATERALS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 46.STAINLESS STEEL IMPLANTS MARKET, 2020–2030 ($MILLION)
FIGURE 47.TITANIUM ALLOY MARKET, 2020–2030 ($MILLION)
FIGURE 48.TITANIUM ALLOY MARKET, 2020–2030 ($MILLION)
FIGURE 49.OTHERS MARKET, 2020–2030 ($MILLION)
FIGURE 50.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANT MARKET FOR CERAMIC BIOMATERIAL, BY COUNTRY, 2020 & 2030 (%)
FIGURE 51.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET POLYMERIC BIOMATERIALS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 52.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR OTHERS BIOMATERIAL, BY COUNTRY, 2020 & 2030. (%)
FIGURE 53.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR KNEE, BY COUNTRY, 2020 & 2030 (%)
FIGURE 54.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR HIP, BY COUNTRY, 2020 & 2030 (%)
FIGURE 55.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR WRIST & SHOULDER, BY COUNTRY, 2020 & 2030 (%)
FIGURE 56.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR DENTAL, BY COUNTRY, 2020 & 2030 (%)
FIGURE 57.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR SPINE, BY COUNTRY, 2020 & 2030 (%)
FIGURE 58.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR ANKLE, BY COUNTRY, 2020 & 2030(%)
FIGURE 59.COMPARATIVE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 60.CONMED: NET SALES, 2018–2020 ($MILLION)
FIGURE 61.CONMED: REVENUE SHARE BY PRODUCT, 2020 (%)
FIGURE 62.CONMED: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 63.COLFAX: NET SALES, 2018–2020 ($MILLION)
FIGURE 64.COLFAX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65.COLFAX: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 66.GLOBUS MEDICAL, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 67.GLOBUS MEDICAL, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 68.GLOBUS MEDICAL, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 69.J&J: REVENUE, 2018–2020 ($MILLION)
FIGURE 70.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 71.J&J: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 72.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 73.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 74.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 75.NUVASIVE: NET SALES, 2018–2020 ($MILLION)
FIGURE 76.NUVASIVE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 77.NUVASIVE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 78.SMITH & NEPHEW: NET SALES, 2018–2020 ($MILLION)
FIGURE 79.SMITH & NEPHEW: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 80.SMITH & NEPHEW: REVENUE SHARE BY REGION, 2020(%)
FIGURE 81.STRYKER: NET SALES, 2018–2020 ($MILLION)
FIGURE 82.STRYKER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 83.STRYKER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 84.ZIMMER BIOMET: NET SALES, 2018–2020 ($MILLION)
FIGURE 85.ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 86.ZIMMER BIOMET: REVENUE SHARE BY REGION, 2020 (%)
The adoption of orthopedic implants (such as orthopedic rods, plates, prosthesis) is expected to witness a significant rise with increase in prevalence of orthopedic diseases and rapid growth in aging population. The orthopedic implants market has piqued the interest of healthcare providers owing to numerous benefits offered by these devices to treat several clinical disorders. There has been remarkable technological advancements to provide advanced treatment options for the management of orthopedic diseases. As the market is saturated with steady growth rate in developed nations, the Asia-Pacific and LAMEA regions are expected to offer high growth opportunities to the key players.
An orthopedic implant is a medical device that is surgically placed in the body. These medical devices are designed to restore function by replacing or reinforcing a damaged structure due to any accident or medical conditions. Growth in incidence of orthopedic diseases, surge in geriatric population across the globe, technological advancements, rise in acceptance of orthopedic implants, and improvement of healthcare infrastructure in emerging nations are some of the major factors that drive this market. However, high cost of implants associated procedures, reimbursement issues, and stringent regulatory policies for the approval of these implants are expected to restrain the market growth. In addition, emerging markets gain more importance for the majority of the orthopedic implant manufacturers and distributors. Rapid growth was observed in the shipments of these devices to provide improved healthcare services in emerging nations, and this is expected to offset the challenging conditions in mature markets such as North America and Europe. North America is expected to dominate the global orthopedic implants market during the forecast period, followed by Europe.
A. The total market value of Orthopedic Implants market is $45,053.00 million in 2020.
A. The forcast period for Orthopedic Implants market is 2021 to 2030
A. The market value of Orthopedic Implants market in 2021 is $45,593.70 million.
A. The base year is 2020 in Orthopedic Implants market
A. Top companies such as Johnson & Johnson, Zimmer Biomet Holdings, Inc., Stryker Corporation, Medtronic Plc, and Smith and Nephew plc. held a high market position in 2020.
A. Reconstructive joint replacements segment is the most influencing segment owing to rise in prevalence of osteoporosis and osteoarthritis, and investment of key players in R&D of orthopedic implants.
A. Rise in prevalence of orthopedic injuries or diseases and the rapid rise in geriatric population. In addition, technological innovations, such as robot-assisted surgical tools, acceptance for implantable medical devices, and widespread application of orthopedic implants to treat musculoskeletal, orthopedic diseases, & injuries further supplement the market growth.
A. Asia-Pacific is expected to experience the highest growth rate during the forecast period, owing to development in healthcare infrastructure, improvement in health awareness and rise in diagnosis, rise in incidences of orthopedic disease such as arthritis, Osteoarthritis and others.
A. Orthopedic implants are medical devices that are used to replace or provide support to damaged bones or joints.
A. Orthopedic Implants usedto restore bone function by reinforcing or replacing a damaged structure.
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
